Arena Pharmaceuticals, Inc. - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Arena Pharmaceuticals, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Arena Pharmaceuticals, Inc.. The Group's principal activities are to discover, develop and commercialize novel and improve orally available drugs that address major unmet medical needs. The Group develops and commercializes oral drugs in therapeutic areas like cardiovascular, central nervous system, inflammatory and metabolic diseases. The Group has active collaborations with two major pharmaceutical companies, Ortho-McNeil-Janssen Pharmaceuticals Inc, for the treatment of type 2 diabetes and Merck & Co Inc, for the treatment of atherosclerosis and related disorders. The Group has a pipeline of internally discovered small molecule drug candidates that target G protein-coupled receptors. The Group operates in the United States.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report